Rohto Pharmaceutical Co.

Rohto Pharmaceutical Co., Ltd.

Native name	ロート製薬株式会社
Type	kabushiki gaisha
Traded as	: OSE: 4527
Industry	Fast-moving consumer goods and pharmaceutical industry
Founded	Higashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
Founder	Yasutami Yamada
Headquarters	Ikuno-ku, Osaka, Japan
Key people	Kunio Yamada (chair and CEO, great-grandson of the founder) Toshiaki Yoshino (president and COO)
Revenue	¥120,292 million (FY 2011) ¥115,472 million (FY 2010)
Operating income	¥13,624 million (FY 2011) ¥13,105 million (FY 2010)
Net income	¥8,184 million (FY 2011) ¥7,966 million (FY 2010)
Total assets	¥136,008 million (FY 2011) ¥126,472 million (FY 2010)
Total equity	¥83,627 million (FY 2011) ¥77,911 million (FY 2010)
Number of employees	5,518 (March 31, 2013)
Website	www.rohto.co.jp/global/
Footnotes / references

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha^?) is a multinational fast-moving consumer goods and OTC pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. The company is listed on the stock exchange having posted steady increases in revenues from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin Care contributes to 61.3% of the revenues while Eye Care contributes to 21% of their sales.

Rohto is active in the three consumer segments of:

In 1974, Rohto set its eyes on The Mentholatum Company. In August 1975, it acquired the trademark rights to Mentholatum and began to sell the Mentholatum Ointment and Mentholatum Medicated Lip Stick, which proved to be a financial success as the company's revenue skyrocketed to ¥2.64 billion by April 1981. Rohto Pharmaceutical Co. continued to acquire the management rights to The Mentholatum Company Inc in June 1988, thus completing the merge.

Rohto group has established operations in 15 major markets, with marketing/distribution agreements in more than 150 countries globally. They have two production plants in Japan and 6 production plants across US, UK, China, Vietnam, Hong Kong and Indonesia.

Rohto entered the Vietnam market in 1997 and set up their manufacturing base to cater to the Asia Pacific market. In mid-2010, Rohto entered the India market and started operations in the lipcare and skin care segment, with their internationally popular brands, Lipice and Oxy. Simultaneously they also entered the Bangladesh market.

With a strong presence across international markets, the company has a manpower strength of close to 5000 employees.